Josh Seidenfeld

Josh is the global chair of Cooley’s digital health group and serves on the firm’s Life Sciences Advisory Board. He represents life sciences, healthcare and technology clients through the full company life cycle, from seed stage through private financings, M&A and initial public offerings. He also regularly advises clients on general corporate issues, securities matters and implications of proposed business transactions. 

Since 2020, Josh has handled 300+ venture capital financings with an aggregate deal value of more than $8.1 billion. Josh counsels clients across industries, including companies operating in the biotechnology, therapeutics, pharma, cybersecurity, artificial intelligence, climate tech and energy, digital health, open source, medical technology and software sectors.

Josh previously worked in the healthcare industry at Practice Fusion, a web-based electronic health records company, where he was corporate counsel and director of business development. In this role, he was responsible for generating revenue, leading the company through complex regulations governing digital healthcare and records, negotiating contracts and more.

Josh is a contributing editor for Cooley GO, the firm’s online resource containing tools, documents, guidance and data for entrepreneurs and emerging companies.